Castle Biosciences (CSTL) Leases: 2021-2025
Historic Leases for Castle Biosciences (CSTL) over the last 4 years, with Sep 2025 value amounting to $15.2 million.
- Castle Biosciences' Leases rose 27.28% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 27.28%. This contributed to the annual value of $11.6 million for FY2024, which is 5.87% down from last year.
- Per Castle Biosciences' latest filing, its Leases stood at $15.2 million for Q3 2025, which was down 2.27% from $15.5 million recorded in Q2 2025.
- Castle Biosciences' Leases' 5-year high stood at $15.5 million during Q2 2025, with a 5-year trough of $7.0 million in Q2 2022.
- Its 3-year average for Leases is $12.3 million, with a median of $11.6 million in 2024.
- As far as peak fluctuations go, Castle Biosciences' Leases surged by 64.99% in 2022, and later declined by 7.86% in 2023.
- Castle Biosciences' Leases (Quarterly) stood at $7.4 million in 2021, then soared by 64.99% to $12.2 million in 2022, then climbed by 1.03% to $12.3 million in 2023, then declined by 5.87% to $11.6 million in 2024, then rose by 27.28% to $15.2 million in 2025.
- Its last three reported values are $15.2 million in Q3 2025, $15.5 million for Q2 2025, and $11.2 million during Q1 2025.